The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.
News: Gynecologic Cancer
In her life, Jessi Zazu, 27, has toured the world as a musician in the group Those Darlins, recorded three studio albums, starred in music videos and exhibited her original artwork in individual and group art shows. With parents who are artists and a father and grandfather who played music, Zazu was destined to inherit […]
The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses. To enlighten the public about these risks, the Prevent Cancer Foundation, in collaboration with Vanderbilt-Ingram Cancer Center (VICC), is sponsoring “Think About the Link,” a seminar […]
Blood type may impact survival in ovarian cancer, the fifth leading cause of cancer deaths among women in the United States. Patients with type A blood showed significantly longer survival than those with other blood types, according to a recent study by Alicia Beeghly-Fadiel, MPH, Ph.D., and colleagues.
Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. “HPV is the most commonly sexually transmitted infection in […]
Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. […]
Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Recognizing a critical need to improve national vaccination rates for HPV, Vanderbilt-Ingram Cancer Center (VICC) is again uniting with […]
Ronald David Alvarez, M.D., Ellen Gregg Shook Culverhouse Chair in the Division of Gynecologic Oncology and vice chair of the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham, has been named chair of the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center. His appointment is effective Sept. 1. Alvarez […]
Contact: Dagny Stuart, (615) 936-7245 Dagny.firstname.lastname@example.org In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in urging increased HPV vaccination for the prevention of cancer. Experts at VICC, in collaboration with colleagues at the other cancer centers, recognize […]
Despite increasingly advanced treatments, nearly half the women who contract ovarian cancer will die within five years. Chemotherapy drug resistance significantly contributes to the high mortality rate. Understanding the processes that trigger tumor growth allows scientists to find better ways to treat this disease. Members of the laboratory of Hal Moses, M.D., previously identified the […]